VOLUME 10 NUMBER 4 • NOVEMBER 2013
133
SA JOURNAL OF DIABETES & VASCULAR DISEASE
RESEARCH ARTICLE
the young age range of the participants, the findings cannot be gen-
eralised to the entire population with T1DM. Nonetheless, the current
findings highlight the need for future studies on larger sample sizes.
This is particularly important, as the incidence of T1DM in developing
countries is observed to be gradually increasing annually.
Acknowledgements
The authors acknowledge Ms Ifeanyi Oranye for acting in the role
of research assistant during the write up of this article.
References
1.
Maia CAS, Campos CAH. Diabetes mellitus as etiological factor of hearing loss.
Brazil J Otorhinolaryngol
2005;
71
(2): 208–214.
2.
Menon PSN, Bajpai A. Diabetes in the Developing Countries. In: Menon RK,
Sperling MA (eds).
Pediatric Diabetes
. Massachusetts: Kluwer Academic, 2003:
165–184.
3.
Mbanya JC, Ramiaya K. Diabetes in sub-Saharan Africa on increase.
J Endocrinol,
Metab Diabetes S Afr
2007;
12
(1): 2–3.
4.
Lisowska G, Namysłowski G, Morawski K, Strojek K. Cochlear dysfunction and
diabetic microangiopathy.
Scand Audiol
2001;
30
(1), 199–203.
5.
Holt IG, Hanley NA.
Essential Endocrinology and Diabetes
. 5th edn. Massachusetts:
Blackwell, 2007.
6.
Feldman EL, Stevens MJ, Russell JW, Greene DA. Somatosensory neuropathy. In:
Porte D, Sherwin RS, Baron A (eds).
Ellenberg and Rifkin’s Diabetes Mellitus
. Ohio:
McGraw Hill, 2003, 771–788.
7.
Fukushima H, Cureoglu S, Schachern PA, Kusunoki T, Oktay MF, Fukushima N,
et
al
. Cochlear changes in patients with type i diabetes mellitus.
Otolaryngol
–
Head
Neck Surg
2005;
133
: 100–106.
8.
Fowler PD, Jones NS. Review: Diabetes and Hearing Loss.
Clin Otolaryngol
1999;
24
: 3–8.
9.
Ferrer JP, Biurrun O, Lorente J, Conget JI, Espana R, Esmatjes E,
et al
. Auditory
Function in Young Patients with Type I Diabetes Mellitus.
Diabetes Res Clin Pract
1991;
11
: 17–22.
10. Cullen JR, Cinnmond MJ. Hearing Loss in Diabetics.
J Laryngol Otol
1993;
107
:
179–182.
11. Lisowska G, Namyslowski G, Morawski K, Strojek K. Early Detection of Cochlear
Dysfunction in Type I Diabetic Patients with and Without Microangiopathy.
J
Audiolog Med
2000;
9
(1): 35–42.
12. Di Nardo WD, Ghirlanda G, Paludetti G, Cercone S, Saponara C, Ninno MN, et al.
Distortion-product otoacoustic emissions and selective sensorineural hearing loss
in IDDM.
Diabetics Care
1998;
21
(8): 1317–1321.
13. Ottaviani F, Dozio N, Neglia CB, Riccio S, Scavini M. Absence of otoacoustic
emissions in insulin-dependent diabetic patients: is there evidence for diabetic
cochleopathy?
J Diabetes Complic
2002;
16
: 338–343.
14. Pessin ABB, Martins RHG, Pimenta WP, Simões ACP, Marsiglia A, Amaral AV.
Auditory evaluation in patients with type 1 diabetes.
Ann Otol Rhinol Larynol
2008;
117
(5): 366–370.
15. Lasisi OA, Nwaorgu OGB, Bella AF. Cochleovestibular complications of diabetes
mellitus in Ibandan, Nigeria.
Int Cong Ser
2003;
1240
: 1325–1328.
16. Robinette MS, Cevette MJ. Case history: integrating audiologic results and
clinical decision analysis. In: Katz J (ed).
Handbook of Clinical Audiology
, 5th edn.
Baltimore: Lippincott Williams & Wilkins, 2002: 142–159.
17. Rappaport JM, Provencal C. Neuro-otology for audiologists. In: Katz J (ed).
Handbook of Clinical Audiology
, 5th edn. Baltimore: Lippincott Williams &
Wilkins, 2002: 9–13.
18. Fowler CG, Shanks JE. Tympanometry. In: Katz J (ed).
Handbook of Clinical
Audiology
, 5th edn. Baltimore: Lippincott Williams & Wilkins, 2002: 175–205.
19. Gelfand SA. The acoustic reflex. In: Katz J (ed).
Handbook of Clinical Audiology
,
5th edn. Baltimore: Lippincott Williams & Wilkins, 2002: 205–233.
20. Hall JW, Mueller HG. Audiologists’
Desk Reference: Diagnostic Audiology
Principles, Procedures and Practices. (Volume 1).
San Diego: Singular, 1997.
21. Roeser RJ, Clark JL. Pure-tone tests. In: Roeser RJ, Valente M, Hosford-Dunn H
(eds).
Audiology Diagnosis
, 2nd edn. New York: Thieme Medical, 2007: 238–
261.
22. Brandy WT. Speech audiometry. In: Katz J (ed).
Handbook of Clinical Audiology
,
5th edn. Baltimore: Lippincott Williams & Wilkins, 2002: 96–111.
23. Lonsbury-Martin BL, Martin GK. Otoacoustic emissions. In: Burkard RF, Don M,
Eggermont JJ (eds). Auditory Evoked Potentials:
Basic Principles and Clinical
Application
. Baltimore: Lippincott Williams & Wilkins, 2007: 159–179.
24. Forzano LB, Gravetter FJ.
Research Methods for the Behavioral Sciences
. 3rd edn.
Belmont: Wadsworth Cengage Learning, 2008.
25. Peers I.
Statistical Analysis for Education and Psychology Researchers
. London:
Felmar Press, 1996.
26. Dewberry C.
Statistical Methods for Organizational Research Theory and Practice
.
Oxon: Routledge, 2004.
27. Jackson SL.
Research Methods and Statistics: A Critical Thinking Approach
. 3rd
edn. Belmont: Wadsworth, 2009.
28. Hall JW.
Handbook of Otoacoustic Emissions
. Canada: Singular Publishing Group,
2000.
29. Ferrer JP, Biurrun O, Lorente J, Conget JI, de España R, Esmatjes E, Gomis R.
Auditory function in young patients with type 1 diabetes mellitus.
Diabetes Res
and Clin Pract
1991;
11
(1): 17–22.
30. Jorgensen MB. The inner ear in diabetes mellitus. Histological studies.
Arch
Otolaryngol
1961;
74
: 373–381.
31. Lisowska G, Namyslowski G, Morawski K, Strojek K. Early Identification of Hearing
Impairment in Patients with Type 1 Diabetes Mellitus.
Otology & Neurotology
2001;
22
: 316–320.
32. Parving A, Elberling C, Balle V, Parbo J, Dejgaard A, Parving H-H. Hearing disorders in
patients with insulin-dependant diabetes mellitus.
Audiology
1990;
29
: 113–121.
33. Gawron W, Pospiech L, Noczynska A, Koziorowska E. Sudden hearing loss as a
first complication of longstanding type 1 diabetes mellitus: A case report.
Diabetic
Med
2003;
21
: 96–98.
34. Ryan AF. The basics, the science and the future potential of otoacoustic emissions.
In: Robinette MS, Glattke TJ (eds).
Otoacoustic Emissions: Clinical Applications
,
3rd edn. New York: Thieme Publishers, 2007: 7–43.
35. Prieve BA, Fitzgerald TS. Otoacoustic emissions. In: Katz J (ed).
Handbook of
Clinical Audiology
, 5th edn. Baltimore: Lippincott Williams & Wilkins, 2002:
440–466.
16. Campbell RJ, Bell CM, Paterson JM,
et al
. Stroke rates after introduction of
vascular endothelial growth factor inhibitors for macular degeneration: a time
series analysis.
Ophthalmology
2012;
119
: 1604–1608.
17. Silva, R, Axer-Siegel R, Eldem,
et al
. The SECURE study: long-term safety of
ranibizumab 0.5 mg in neovascular age-related macular degeneration.
Ophthal-
mology
2013;
120
: 130–139.
18. Semeraro F, Morescalchi F, Parmeggiani F,
et al
. Aflibercept in wet AMD: specific
role and optimal use.
Drug Des Devel Ther
2013;
7
: 711–722.
19. Kumar B, Gupta SK, Saxena R, Srivastava S. Current trends in the pharmacotherapy
of diabetic retinopathy.
J Postgrad Med
2012;
58
: 132–139.
20. TothPP,SimkoRJ,PalliSR,
etal
.The impactofserum lipidsonriskformicroangiopathy
in patients with type 2 diabetes mellitus.
Cardiovasc Diabetol
2012;
11
: 109.
21. Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation
versus pars plana vitrectomy with internal limiting membrane removal in diabetic
macular edema.
Am J Ophthalmol
2005;
139
: 795–801.
22. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal
of the internal limiting membrane in the treatment of persistent diabetic macular
edema.
Am J Ophthalmol
2005;
139
: 447–454.
23. Heij ECL, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic
macular oedema without evident vitreomacular traction.
Graefes Arch Clin Exp
Ophthalmol
2001;
239
: 264–270.
24. Diaz-Llopis M, Udaondo P, Arevalo F,
et al
. Intravitreal plasmin without associated
vitrectomy as a treatment for refractory diabetic macular edema.
J Ocul Pharmacol
Ther
2009;
25
: 379–384.
25. Furlani BA, Meyer CH, Rodrigues EB,
et al
. Emerging pharmacotherapies for
diabetic macular edema.
Expert Opin Emerg Drugs
2007;
12
: 591–603.
26. Wang H, Sun X, Liu K, Xu X. Intravitreal ranibizumab (lucentis) for the treatment
of diabetic macular edema: a systematic review and meta-analysis of randomized
clinical control trials.
Curr Eye Res
2012;
37
: 661–670.
27. Zhang X-L, Chen J, Zhang RJ,
et al
. Intravitreal triamcinolone versus intravitreal
bevacizumab for diabetic macular edema: a meta-analysis.
Int J Ophthalmol
2013;
6
: 546–552.
Continued from page 121
